(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
One of the best meteor showers of the year peaks at the worst possible time this week - 2Chinese mega embassy could bring security advantages, says No 10
- 3US EPA will reassess safety of herbicide paraquat, says its chief
- 4Blue Origin's next space tourism flight will break new ground for people with disabilities
- 5Protester climbs on to balcony of Iranian embassy in London
- Mother and Stepson Rescued After Being Swept Over 6 Miles in Paddleboarding Mishap
- Hubble sees spiral galaxy in Lion's heart | Space photo of the day for Nov. 4
- Moscow accuses Berlin of stifling the opposition
- From Iran to Israel: An Iranian volunteer’s unlikely stand in wartime
- Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
- Taylor Frankie Paul's domestic violence case is fueling discussions about DARVO. Experts say terms like this shouldn't be used lightly.
- How to sound like an astronaut as you follow the first human moon mission in more than half a century
- Top 10 Moving Style Architects of the Year
- 'Stranger Things' Season 5: What's going on with Will Byers? That shocking Volume 1 plot twist, explained.
